Aclaris Therapeutics Inc

Small-Cap Stocks Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$3.69

-0.05 (-1.34%)

As of Mar 22, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 86%

Hold 2 14%

Sell 0 0%

Price Target

Analyst Price Target +382.1% upside

Low Target $13.99

Average Target $17.79

High Target $22.90

Current Price $3.69

Current
$3.69

Target
$17.79

$13.99 $17.79 avg $22.90

Scenario Analysis

Bear Case

$13.99

279.1%

Low target

Base Case

$17.79

+382.1%

Avg target

Bull Case

$22.90

+520.6%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$4.89

-24.5% from high

52-Week Low

$1.05

+251.4% from low

Target vs 52W High

$17.79

+263.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%